Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Antiallergic/antiinflammatory agents in the Nikken Chemicals pipeline

May 11, 1999

New peptide tachykinin antagonists from Asahi Glass

May 11, 1999

Flixotide submitted for COPD in major markets

May 10, 1999

NA-00226B and C, produced by Streptomyces, inhibit cAMP PDE activity

May 10, 1999

Chugai and Dainippon Ink & Chemicals to codevelop new antiallergic agent

May 6, 1999

Alpha1-antitrypsin may be a future treatment for asthma

May 6, 1999

Progress in ARDS/ALI studies of lisofylline reported

May 6, 1999

Celltech reports new developments in the field of PDE4 inhibitors

May 5, 1999

Serine protease inhibitors designed at Glaxo Wellcome

May 4, 1999

Elastase inhibitors synthesized at Glaxo Wellcome, useful for chronic bronchitis

May 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...